VRNA
Verona Pharma
VRNA
VRNA
Delisted
VRNA was delisted on the 6th of October, 2025.
68 hedge funds and large institutions have $474M invested in Verona Pharma in 2022 Q3 according to their latest regulatory filings, with 35 funds opening new positions, 15 increasing their positions, 7 reducing their positions, and 6 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
75% more funds holding in top 10
Funds holding in top 10: 4 → 7 (+3)
70% more funds holding
Funds holding: 40 → 68 (+28)
1.66% more ownership
Funds ownership: 7.27% → 8.93% (+1.7%)
Holders
68
Holding in Top 10
7
Calls
$5.57M
Puts
$1.89M
Top Buyers
| 1 | +$28.9M | |
| 2 | +$21.8M | |
| 3 | +$21.5M | |
| 4 |
FFM
Fairmount Funds Management
West Conshohocken,
Pennsylvania
|
+$17.9M |
| 5 |
VC
Vivo Capital
Palo Alto,
California
|
+$15.3M |
Top Sellers
| 1 | -$3.19M | |
| 2 | -$3.15M | |
| 3 | -$1.76M | |
| 4 |
WP
Woodline Partners
San Francisco,
California
|
-$1.29M |
| 5 |
VP
venBio Partners
San Francisco,
California
|
-$678K |